Package 50268-145-15

{"route": ["SUBLINGUAL"], "spl_id": "47e23f4e-d4aa-7af1-e063-6394a90a2f05", "openfda": {"unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["b955054b-b37d-4079-4fed-5939b763ecb4"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15)  / 1 TABLET in 1 BLISTER PACK (50268-145-11)", "package_ndc": "50268-145-15", "marketing_start_date": "20161208"}], "brand_name": "Buprenorphine HCl and Naloxone HCl", "product_id": "50268-145_47e23f4e-d4aa-7af1-e063-6394a90a2f05", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "50268-145", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl and Naloxone HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA203136", "marketing_category": "ANDA", "marketing_start_date": "20161208", "listing_expiration_date": "20271231"}